Molecularly guided venetoclax duration in older adults with AML: Lessons from the OPTI-AML trial

Jiandong Shi, Chunmeng Rong, Yiqin Weng

doi:10.1016/j.lrr.2026.100606

CrossrefInfo card

Molecularly guided venetoclax duration in older adults with AML: Lessons from the OPTI-AML trial

Jiandong Shi, Chunmeng Rong, Yiqin Weng

Leukemia Research Reports · 2026 · 26 · 100606

DOI: 10.1016/j.lrr.2026.100606 ↗

Abstract Bibliographic details

Abstract

No abstract available.

Bibliographic details

Authors: Jiandong Shi, Chunmeng Rong, Yiqin Weng
Journal: Leukemia Research Reports
Year of publication: 2026
Volume / Issue: 26
Pages: 100606
Publisher: Elsevier BV
DOI: 10.1016/j.lrr.2026.100606
ISSN: 2213-0489
Source: Crossref

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.